Sponsor Pipeline

First Affiliated Hospital of Fujian Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
48
Active Trials
35
Recruiting
1
Phase 3
10
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06520319
Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary…
overall status: Recruiting → Unknown
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-04 NCT07743866 Optimizing Parameters of Transcranial Temporal Interference Stimulation for… Not Yet Recruiting
Active Trials by Phase
Phase 2/3
1
Phase 2
2
Phase 1/2
4
Phase 1
2
Early Phase 1
10
Not specified
29
Active Trials — top 25 of 48
NCT IDTitleConditionStatus
Phase 2/3
NCT07209878 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With… Prostate Cancer (Adenocarcinoma) Recruiting
Phase 2
NCT06791083 Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant… Gastric Cancer Recruiting
NCT07562438 Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic… Prostate Cancer Recruiting
Phase 1/2
NCT07056790 Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and… Prostate CA Recruiting
NCT07363382 The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer Prostate Cancer (Adenocarcinoma) Recruiting
NCT07363486 Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant… Prostate Cancer Recruiting
NCT07117760 Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic… Prostate Cancer Active, Not Recruiting
Phase 1
NCT06181032 A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary… Biliary Tract Malignancies Recruiting
NCT07681141 Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies Patients With Advanced Metastatic FAP-Positive Tumors Active, Not Recruiting
Early Phase 1
NCT06612580 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study Prostate Cancer (Adenocarcinoma) Recruiting
NCT06636617 177Lu-JH04 in Patients with FAP-Positive Tumors Patients with Advanced Metastatic FAP-Positive Tumors Recruiting
NCT06438250 68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies Malignant Neoplasm Recruiting
NCT06688188 68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study Malignant Neoplasm Recruiting
NCT06688305 68Ga-NI-FAPI PET/CT: First-in-human Study Malignant Neoplasm Recruiting
NCT06734572 18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study Malignant Neoplasm Recruiting
NCT06740240 68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer Tumor Recruiting
NCT06995976 Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73 Malignant Tumour Recruiting
NCT04499365 68Ga-FAPI PET/CT in Patients With Various Types of Cancer Tumor Recruiting
NCT04504526 Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in… Lymphoma Recruiting
Not specified
NCT04008329 A Registered Cohort Study on Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis Recruiting
NCT05284318 Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in… Periprosthetic Joint Infection Recruiting
NCT06600815 Analgesic Efficacy of Preemptive Stepwise Infiltration Anesthesia for Perioperative… Total Knee Arthroplasty Recruiting
NCT06233838 Multi-center Clinical Study on Hemoperfusion of KHA80 Uremia Recruiting
NCT04686877 Safety and Efficacy of Stereotactic Aspiration Plus Urokinase in Deep Intracerebral… Treatment of Spontaneous Intracerebral Hemorrhage Recruiting
NCT06977906 Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer… Robotic-Assisted Radical Prostatectomy Recruiting
See all 48 active First Affiliated Hospital of Fujian Medical University trials with filters →
Disease Areas
Get alerts when First Affiliated Hospital of Fujian Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free